摘要
蒙药乌兰—13 味汤(WL—13)最早记载于《通瓦嘎吉德》,之后收录于 1998 年版《中华人民共和国卫生部药品标准》(蒙药分册)中.WL—13 由栀子、诃子、川楝子、土木香、山柰、悬钩木、苦参、茜草、紫草、紫草茸、枇杷叶、金莲花、橡子等 13 种单味药材配伍组成,具有清血热的功效,主治血热盛行、头痛、目赤、高血压、成熟热与未成熟热、感冒、白脉病、肺热、鼻出血、皮疹、中暑、风湿、类风湿等诸疾,具有良好的潜在研究价值.本综述探析了WL—13 的历史沿革、方解、临床应用及实验研究进展,以期为该药的现代化研究提供理论支撑.
Abstract
The Mongolian medicine Wulan—13(WL—13)decoction was first recorded in the"Tongwagajid",and then included in the 1998 edition of the"Drug Standards of the Ministry of Health of the People's Republic of China"(Mongolian Medicine Volume).It is composed of Gardeniae fructus,Chebulae fructus,Toosendan fructus,Inula helenium,Kaempferia galanga,Rubus sachajinensis,Sophora flavescens,Rubia cordifolia,Arnebia guttata bunge,Eriobotrya japonica leaf,Trollius chinensis bumge,Trollius chinensis and Acorn.WL—13 decoction has the efficacy for abatement of fever,and is mainly used to treat Xuere,headache,conjunctival hyperemia,hypertension,fever,cold,white-pulse disease,pneumonia,epistaxis,skin rash,heatstroke,rheumatism,rheumatoid arthritis and other diseases,and have potential research value.This review explores the historical history,prescription explanation,clinical application and experimental research progress of WL—13,with a view to providing theoretical support for the modernization research of WL—13.
维普
万方数据